Avelumab, Palbociclib and Axitinib in Advanced RCC

Clinical trial NCT05176288 · WITHDRAWN

Trial details

NCT number: NCT05176288
Sponsor: Bradley A. McGregor, MD
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Clear Cell Renal Cell Carcinoma

Start date: 2024-05-31
Primary completion: 2026-08-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.